Our Work
At AdRegeneer, innovation is at the heart of everything we do. Every member of our team is deeply committed to the mission of bringing regenerative treatments for the nervous system to those in need. Our work is not merely a job—it is a calling to make a lasting impact on the lives of patients battling neurodegenerative diseases and traumatic injuries.
HDAC2 activator
We are proud to introduce our revolutionary remyelination-specific formulation for an HDAC2 activator, a re-purposed molecule with the potential to unlock new possibilities for multiple sclerosis patients. Excitingly, we are on the cusp of launching our first Phase II clinical trial project, aimed at assessing the efficacy of this molecule in repairing lesions and restoring lost functions in individuals affected by multiple sclerosis.
HDAC2 activator
We are proud to introduce our revolutionary remyelination-specific formulation for an HDAC2 activator, a re-purposed molecule with the potential to unlock new possibilities for multiple sclerosis patients. Excitingly, we are on the cusp of launching our first Phase II clinical trial project, aimed at assessing the efficacy of this molecule in repairing lesions and restoring lost functions in individuals affected by multiple sclerosis.